RCKT · Rocket Pharmaceuticals, Inc.
$3.47
+0.13 (+3.89%)
At close · Aug 14
Market Cap
$380.92M
Shares
109.77M
Rocket Pharmaceuticals, Inc. Earnings Call Transcripts
Every quarterly earnings call for Rocket Pharmaceuticals, Inc. (RCKT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-27
KRESLADI™ FDA Approval Investor Conference Call
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-27
Rocket Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Revenue
$
Diluted EPS
$-0.56
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Rocket Pharmaceuticals, Inc. Q2 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-0.55
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Rocket Pharmaceuticals, Inc. Q1 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-0.65
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts
CIK
1281895
CUSIP
77313F106
13F (30d)
178 filings
172 filers
Visit website
Investor relations